What is VIVS's relative strength rating?

VIVS ranks at the 14th percentile over 1 month, 7th percentile over 3 months, 12th percentile over 6 months, 23th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is VIVS in?

VIVS is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.

Is VIVS in a leading sector?

Sector RS percentile is not available for Healthcare at this snapshot. Leading sector status (threshold: Healthcare RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.

How volatile is VIVS?

VIVS currently shows a 20-day average daily range (ADR%) of 6.7%, a 90-day beta versus the S&P 500 of 1.73. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does VIVS have a seasonal pattern?

TickerStance computes VIVS's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what VIVS has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did VIVS last report earnings?

VIVS most recently filed a 10-Q covering FY25 Q3 with the SEC on 2026-02-11. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

VivoSim Labs, Inc. Common Stock (VIVS) · RS 12

Free

Loading ticker…

Dossier · Pro

VivoSim Labs, Inc. Common Stock · Healthcare · Pharmaceutical Products

$1.03▼-3.74%

Neutral · stance 47

TODAY'S READ · AS OF 2026-06-26

As of 2026-06-26, VivoSim Labs, Inc. Common Stock (VIVS) has a 3-month relative strength percentile of 7 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 34. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.7%, relative volume 0.77×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

VIVSVivoSim Labs, Inc. Common Stock

$1.03-0.04 ▼ -3.74%

RS 7·−81% from high·−21% vs 50D

RANGE

VIVS daily OHLC, last 60 sessions
Date	Open	High	Low	Close	Volume
2026-04-01	1.31	1.67	1.25	1.62	298675.831393
2026-04-02	1.50	1.71	1.47	1.69	56035.698764
2026-04-06	1.65	1.76	1.62	1.71	122667.044113
2026-04-07	1.72	1.87	1.60	1.62	68025.383138
2026-04-08	1.65	1.65	1.56	1.58	29504.182786
2026-04-09	1.58	1.58	1.52	1.53	19345.754642
2026-04-10	1.50	1.52	1.43	1.45	22803.1218
2026-04-13	1.44	1.47	1.44	1.44	10356.13037
2026-04-14	1.44	1.52	1.44	1.52	18968.437314
2026-04-15	1.60	1.60	1.46	1.51	19312.688509
2026-04-16	1.55	1.55	1.45	1.50	16565.584536
2026-04-17	1.54	1.89	1.51	1.61	71634.516849
2026-04-20	1.55	1.60	1.50	1.54	40641.996942
2026-04-21	1.60	1.60	1.42	1.46	62020.650157
2026-04-22	1.43	1.56	1.43	1.48	56024.305333
2026-04-23	1.58	1.58	1.46	1.48	20510.774
2026-04-24	1.50	1.50	1.42	1.46	15529.053027
2026-04-27	1.52	1.60	1.47	1.50	45738.593884
2026-04-28	1.60	1.67	1.43	1.49	276370.28672
2026-04-29	1.45	1.45	1.36	1.44	46670.62468
2026-04-30	1.44	1.48	1.40	1.43	24977.390743
2026-05-01	1.41	1.55	1.38	1.44	88190.635586
2026-05-04	1.42	1.44	1.39	1.41	20791.782267
2026-05-05	1.43	1.45	1.40	1.42	15436.869261
2026-05-06	1.40	1.48	1.39	1.41	20350.97959
2026-05-07	1.48	1.48	1.41	1.41	50490.781265
2026-05-08	1.40	1.43	1.38	1.39	18667.871661
2026-05-11	1.39	1.41	1.38	1.38	67159.439005
2026-05-12	1.38	1.40	1.30	1.31	40167.367882
2026-05-13	1.30	1.33	1.28	1.30	27631.109484
2026-05-14	1.29	1.34	1.27	1.32	15517.065851
2026-05-15	1.30	1.33	1.28	1.29	11626.936657
2026-05-18	1.28	1.31	1.26	1.27	13466.625
2026-05-19	1.28	1.33	1.26	1.29	18516.61582
2026-05-20	1.27	1.31	1.26	1.30	26373.867196
2026-05-21	1.28	1.35	1.22	1.34	248868.778854
2026-05-22	1.37	1.38	1.30	1.36	37175.91666
2026-05-26	1.35	1.35	1.29	1.29	30011.43479
2026-05-27	1.32	1.34	1.28	1.29	20175.103021
2026-05-28	1.29	1.31	1.25	1.31	25477.744318
2026-05-29	1.30	1.33	1.27	1.31	59515.547042
2026-06-01	1.29	1.30	1.25	1.29	63774.085448
2026-06-02	1.27	1.30	1.26	1.28	31900.5702
2026-06-03	1.29	1.29	1.25	1.26	34899.0291
2026-06-04	1.30	1.35	1.27	1.35	115560.467207
2026-06-05	1.31	1.35	1.18	1.20	200127.471875
2026-06-08	1.21	1.26	1.16	1.19	23836.749926
2026-06-09	1.21	1.21	1.13	1.19	38757.017533
2026-06-10	1.19	1.21	1.15	1.18	15764.921851
2026-06-11	1.18	1.19	1.15	1.16	23927.258081
2026-06-12	1.19	1.26	1.13	1.14	34278.7797
2026-06-15	1.17	1.25	1.17	1.21	66387.391921
2026-06-16	1.19	1.21	1.15	1.17	58606.523163
2026-06-17	1.19	1.19	1.13	1.13	103541.75
2026-06-18	1.15	1.18	1.10	1.10	87931.946338
2026-06-22	1.15	1.21	1.12	1.13	258375.788547
2026-06-23	1.10	1.18	1.10	1.13	64820.371248
2026-06-24	1.15	1.15	1.08	1.09	61673.763715
2026-06-25	1.10	1.13	1.07	1.07	39002.973386
2026-06-26	1.09	1.13	1.02	1.03	54005.592272

2026-06-26·O 1.09H 1.13L 1.02C 1.03-0.04 ▼·VOL 54.0K

SRC · EOD·126 SESSIONS · 1D

§ Seasonality

10y · since 2025

Best monthJan on averageavg +61.33% · 100% win · n 1

Worst monthMar on averageavg -34.10% · 0% win · n 1

VIVS monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	VIVS Jan avg: 61.33% median: 61.33% win: 100% σ: 0.00% n: 1 2025-04-25 → 2026-05-29	VIVS Feb avg: -25.69% median: -25.69% win: 0% σ: 0.00% n: 1 2025-04-25 → 2026-05-29	VIVS Mar avg: -34.10% median: -34.10% win: 0% σ: 0.00% n: 1 2025-04-25 → 2026-05-29	VIVS Apr avg: 2.14% median: 2.14% win: 100% σ: 3.02% n: 2 2025-04-25 → 2026-05-29	VIVS May avg: -8.04% median: -8.04% win: 0% σ: 0.49% n: 2 2025-04-25 → 2026-05-29	VIVS Jun avg: -18.33% median: -18.33% win: 0% σ: 0.00% n: 1 2025-04-25 → 2026-05-29 (current)	VIVS Jul avg: 27.21% median: 27.21% win: 100% σ: 0.00% n: 1 2025-04-25 → 2026-05-29	VIVS Aug avg: 30.48% median: 30.48% win: 100% σ: 0.00% n: 1 2025-04-25 → 2026-05-29	VIVS Sep avg: 19.67% median: 19.67% win: 100% σ: 0.00% n: 1 2025-04-25 → 2026-05-29	VIVS Oct avg: -7.53% median: -7.53% win: 0% σ: 0.00% n: 1 2025-04-25 → 2026-05-29	VIVS Nov avg: -17.04% median: -17.04% win: 0% σ: 0.00% n: 1 2025-04-25 → 2026-05-29	VIVS Dec avg: -19.20% median: -19.20% win: 0% σ: 0.00% n: 1 2025-04-25 → 2026-05-29

Fundamentals · VIVS

Does the business back the chart?

SEC EDGAR · last filing 10-Q · FY25 Q3 · period end 2025-12-31 · Latest filing 137 days old — may be pre-earnings

Fundamentals Growth Rank

How does growth rank vs. the universe?

vs. 3,214 ranked stocks · Sector rank 31

View fundamental leadership map

Laggard

Earnings

Are losses narrowing?

Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.

Loss narrowing

−$0.40—

23 Q3

−$2.74—

24 Q2

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

LDR

—

StageWeinstein stage analysis

Stage 4 · Decline✓

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

ETF OWNERS

ETFs holding VIVS

VIVS appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $22K notional.

ETFs holding: 1
Total value: $22K
Top 3 concentration: 100.0%
Max weight: VXF · 0.00%

Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.

ETFs holding VIVS ranked by value
ETF	Weight	Value
VXFVanguard Extended Market ETF	0.00%	$22K

FAQ

Frequently asked questions

What is VIVS's relative strength rating?: VIVS ranks at the 14th percentile over 1 month, 7th percentile over 3 months, 12th percentile over 6 months, 23th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is VIVS in?: VIVS is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.
Is VIVS in a leading sector?: Sector RS percentile is not available for Healthcare at this snapshot. Leading sector status (threshold: Healthcare RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.
How volatile is VIVS?: VIVS currently shows a 20-day average daily range (ADR%) of 6.7%, a 90-day beta versus the S&P 500 of 1.73. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does VIVS have a seasonal pattern?: TickerStance computes VIVS's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what VIVS has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
When did VIVS last report earnings?: VIVS most recently filed a 10-Q covering FY25 Q3 with the SEC on 2026-02-11. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

§ Seasonality

Does the business back the chart?

Are losses narrowing?

Receipts behind the read

Is it leading?

Who's accumulating?

VIVS is not confirmed as a leader.

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

How much does it move?

Pattern read

Sector context

Who else is leading?

Healthcare

Same industry, closest relative strength

Market backdrop

Is the crowd watching?

Company snapshot

ETFs holding VIVS

Frequently asked questions

§ Seasonality

VivoSim Labs, Inc. Common Stock (VIVS) — Stance & relative strength

Does the business back the chart?

Are losses narrowing?

Receipts behind the read

Is it leading?

Who's accumulating?

VIVS is not confirmed as a leader.

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

How much does it move?

Pattern read

Sector context

Who else is leading?

Healthcare

Same industry, closest relative strength

Market backdrop

Is the crowd watching?

Company snapshot

ETFs holding VIVS

Frequently asked questions